CO6511227A2 - Composiciones alcohólicas que tienen un riesgo reducido de acetaldehidemia - Google Patents

Composiciones alcohólicas que tienen un riesgo reducido de acetaldehidemia

Info

Publication number
CO6511227A2
CO6511227A2 CO12041745A CO12041745A CO6511227A2 CO 6511227 A2 CO6511227 A2 CO 6511227A2 CO 12041745 A CO12041745 A CO 12041745A CO 12041745 A CO12041745 A CO 12041745A CO 6511227 A2 CO6511227 A2 CO 6511227A2
Authority
CO
Colombia
Prior art keywords
ethanol
alcohol
deuterized
induced
alcoholic beverage
Prior art date
Application number
CO12041745A
Other languages
English (en)
Spanish (es)
Inventor
Anthony Czarnik
Jeffrey Mckinney
Original Assignee
Protia Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protia Llc filed Critical Protia Llc
Publication of CO6511227A2 publication Critical patent/CO6511227A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
    • C12C12/00—Processes specially adapted for making special kinds of beer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00—Preparation of other alcoholic beverages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00—Preparation of other alcoholic beverages
    • C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Alcoholic Beverages (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Medicinal Preparation (AREA)
CO12041745A 2009-08-21 2012-03-09 Composiciones alcohólicas que tienen un riesgo reducido de acetaldehidemia CO6511227A2 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27487509P 2009-08-21 2009-08-21
US28086009P 2009-11-09 2009-11-09
US28352409P 2009-12-04 2009-12-04
US12/777,238 US8658236B2 (en) 2009-08-21 2010-05-10 Alcoholic compositions having a lowered risk of acetaldehydemia

Publications (1)

Publication Number Publication Date
CO6511227A2 true CO6511227A2 (es) 2012-08-31

Family

ID=43605849

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12041745A CO6511227A2 (es) 2009-08-21 2012-03-09 Composiciones alcohólicas que tienen un riesgo reducido de acetaldehidemia

Country Status (32)

Country Link
US (6) US8658236B2 (enExample)
EP (1) EP2467465B1 (enExample)
JP (1) JP5862965B2 (enExample)
KR (1) KR101462740B1 (enExample)
CN (2) CN103300449B (enExample)
AP (1) AP3676A (enExample)
AU (1) AU2010284051B2 (enExample)
BR (1) BR112012003560A8 (enExample)
CA (1) CA2771166C (enExample)
CL (1) CL2012000448A1 (enExample)
CO (1) CO6511227A2 (enExample)
CY (1) CY1119041T1 (enExample)
DK (1) DK2467465T3 (enExample)
EA (1) EA023867B1 (enExample)
ES (1) ES2635730T3 (enExample)
GE (1) GEP20146057B (enExample)
HR (1) HRP20171225T1 (enExample)
HU (1) HUE036124T2 (enExample)
IL (1) IL218201A (enExample)
LT (1) LT2467465T (enExample)
ME (1) ME02866B (enExample)
MX (1) MX2012002089A (enExample)
MY (1) MY156177A (enExample)
NZ (1) NZ598452A (enExample)
PL (1) PL2467465T3 (enExample)
PT (1) PT2467465T (enExample)
RS (1) RS56120B1 (enExample)
SG (1) SG178521A1 (enExample)
SI (1) SI2467465T1 (enExample)
SM (1) SMT201700397T1 (enExample)
WO (1) WO2011022682A1 (enExample)
ZA (1) ZA201202075B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3135656T (lt) 2011-06-20 2019-04-25 H. Lundbeck A/S Deuterinti 1-piperazin-3-fenilindanai, skirti šizofrenijos gydymui
US20140079857A1 (en) 2012-04-05 2014-03-20 Anheuser-Busch, Llc Methods for decarbonating fermented liquids
JP6362601B2 (ja) 2012-09-18 2018-07-25 オースペックス・ファーマシューティカルズ・インコーポレイテッドAuspex Pharmaceuticals, Inc. 小胞モノアミン輸送体2の重水素化ベンゾキノリン阻害剤の製剤薬物動態
US9713330B1 (en) 2013-03-15 2017-07-25 Deuteria Agrochemicals, Llc Deuterium-enriched aldehydes
US9023336B2 (en) 2013-03-15 2015-05-05 Deuterra Agrochemicals, LLC Deuterium-enriched aldehydes
DK3194557T3 (da) * 2014-09-16 2020-09-21 Roar Holding Llc Energidrikke og andre ernæringstilsætningsstoffer udledt af agavebaserede spirituosa
WO2016092547A1 (en) * 2014-12-09 2016-06-16 Ezekiel Golan Alcoholic beverage substitutes
PL3265085T3 (pl) * 2015-03-06 2022-11-07 Auspex Pharmaceuticals, Inc. Sposoby leczenia zaburzeń związanych z nieprawidłowymi ruchami mimowolnymi
KR20170032815A (ko) 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
US10289381B2 (en) * 2015-12-07 2019-05-14 Motorola Mobility Llc Methods and systems for controlling an electronic device in response to detected social cues
AU2018260728B2 (en) 2017-04-27 2022-07-21 Deuteria Beverages, Llc Process for the preparation of deuterated ethanol from D2
US10494316B2 (en) 2017-04-27 2019-12-03 Deuteria Beverages, Llc Process for the preparation of deuterated ethanol from D2O
CN109330632B (zh) * 2018-11-09 2023-09-29 上海导向医疗系统有限公司 活检旋切装置
CN113056457B (zh) 2018-12-03 2025-06-20 H.隆德贝克有限公司 用于治疗cns疾病的前药
CA3131237A1 (en) * 2019-02-26 2020-09-03 Tsubame Bhb Co., Ltd. Molded sintered body, and method for producing molded sintered body
US10582716B1 (en) 2019-06-14 2020-03-10 Lennham Pharmaceuticals, Inc. Deuterated caffeine and uses thereof
WO2021086983A1 (en) 2019-10-29 2021-05-06 TMRW Life Sciences, Inc. Apparatus to facilitate transfer of biological specimens stored at cryogenic conditions
US11817187B2 (en) 2020-05-18 2023-11-14 TMRW Life Sciences, Inc. Handling and tracking of biological specimens for cryogenic storage
WO2022066192A1 (en) 2020-09-24 2022-03-31 TMRW Life Sciences, Inc. Cryogenic storage system with sensors to measure one or more parameters therewithin
USD963194S1 (en) 2020-12-09 2022-09-06 TMRW Life Sciences, Inc. Cryogenic vial carrier
CA3200508A1 (en) 2020-12-10 2022-06-16 TMRW Life Sciences, Inc. Specimen holder with wireless transponder for attachment to specimen collection body
AU2022207973B2 (en) 2021-01-13 2024-06-27 Tmrw Life Sciences, Llc Systems, apparatus and methods to pick and/or place specimen containers
US12194046B2 (en) 2021-03-09 2025-01-14 Lennham Pharmaceuticals, Inc. D9-caffeine compositions and uses thereof
US12527318B2 (en) 2021-10-08 2026-01-20 TMRW Life Sciences, Inc. Systems, apparatus and methods to pick and/or place specimen containers

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5156408A (en) * 1974-11-08 1976-05-18 Piasu Chem Co Karubonsanno jusuisokaesuteruno seizohoho
DE3413085A1 (de) 1984-04-06 1985-10-24 Henkell & Co, 6200 Wiesbaden Verfahren zum herabsetzen des alkoholgehalts alkoholhaltiger getraenke, insbesondere wein und schaumwein
US4612196A (en) 1984-08-23 1986-09-16 Miller Brewing Company Preparation of low alcohol beverages by reverse osmosis
US5223269A (en) 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension
HU208084B (en) * 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
JPH05156408A (ja) * 1991-11-29 1993-06-22 Nippon Steel Corp 溶接性に優れた高強度マルテンサイトステンレス鋼とその製造方法
DE4343838C2 (de) 1993-12-22 1998-07-09 Lohmann Therapie Syst Lts Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
CN1143308A (zh) * 1994-01-06 1997-02-19 Hyd探索发展有限公司 预防疾病发生的食品及其制备方法
ATE205055T1 (de) 1994-01-06 2001-09-15 Hyd Kutato Fejleszto Ktf Nahrungsmittel zur verhinderung der entwicklung von erkrankungen und verfahren zur herstellung dieser nahrungsmittel
KR100477070B1 (ko) 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
GB2293100A (en) 1994-09-15 1996-03-20 Medeva Europ Ltd Pharmaceutical compositions with deuterium oxide
KR100387229B1 (ko) 1995-11-01 2003-08-21 삼성전자주식회사 영상부호화장치
US6376531B1 (en) 1998-11-13 2002-04-23 Rupert Charles Bell Method of treatment using deuterium compounds
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
DE10361313B4 (de) 2003-12-19 2008-04-10 Südzucker AG Mannheim/Ochsenfurt Alkoholarme Biere oder bierähnliche Erfrischungsgetränke mit Palatinose
EP1846546B1 (en) * 2005-02-08 2011-04-13 Woodford Associates Limited Alcoholic beverage enriched with 1h216o
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+,k+-atp酶氘代抑制剂
US7713773B2 (en) * 2005-11-02 2010-05-11 Solopower, Inc. Contact layers for thin film solar cells employing group IBIIIAVIA compound absorbers
US20080301122A1 (en) * 2007-05-31 2008-12-04 Amadeus S.A.S. Searching techniques
US20090046823A1 (en) * 2007-08-14 2009-02-19 Texas Instruments Incorporated Neutron generating device

Also Published As

Publication number Publication date
NZ598452A (en) 2012-12-21
US10731116B2 (en) 2020-08-04
US20190062680A1 (en) 2019-02-28
WO2011022682A1 (en) 2011-02-24
BR112012003560A8 (pt) 2020-12-01
IL218201A0 (en) 2012-04-30
RS56120B1 (sr) 2017-10-31
MX2012002089A (es) 2012-07-03
US11298317B2 (en) 2022-04-12
US9044423B2 (en) 2015-06-02
CN103300449B (zh) 2015-05-06
CL2012000448A1 (es) 2012-08-31
US20180030394A1 (en) 2018-02-01
CN102471742A (zh) 2012-05-23
CA2771166A1 (en) 2011-02-24
CN102471742B (zh) 2013-05-29
ME02866B (me) 2018-04-20
JP5862965B2 (ja) 2016-02-16
DK2467465T3 (en) 2017-09-11
MY156177A (en) 2016-01-15
AP3676A (en) 2016-04-16
KR20120053510A (ko) 2012-05-25
ZA201202075B (en) 2013-08-28
SI2467465T1 (sl) 2017-09-29
EA201290097A1 (ru) 2012-08-30
US20160137959A1 (en) 2016-05-19
AU2010284051A1 (en) 2012-03-08
US20150011651A1 (en) 2015-01-08
SG178521A1 (en) 2012-04-27
AU2010284051B2 (en) 2014-12-04
CA2771166C (en) 2015-02-24
US10047330B2 (en) 2018-08-14
LT2467465T (lt) 2017-11-27
BR112012003560A2 (pt) 2020-10-27
EA023867B1 (ru) 2016-07-29
US8658236B2 (en) 2014-02-25
US20210038511A1 (en) 2021-02-11
ES2635730T3 (es) 2017-10-04
SMT201700397T1 (it) 2017-09-07
EP2467465A1 (en) 2012-06-27
HUE036124T2 (hu) 2018-06-28
PL2467465T3 (pl) 2017-11-30
JP2013502227A (ja) 2013-01-24
US20110046236A1 (en) 2011-02-24
HRP20171225T1 (hr) 2017-10-20
PT2467465T (pt) 2017-09-11
GEP20146057B (en) 2014-03-10
CY1119041T1 (el) 2018-01-10
AP2012006133A0 (en) 2012-02-29
KR101462740B1 (ko) 2014-11-17
IL218201A (en) 2015-09-24
CN103300449A (zh) 2013-09-18
EP2467465A4 (en) 2013-09-25
HK1171245A1 (en) 2013-03-22
EP2467465B1 (en) 2017-06-07
US9732311B2 (en) 2017-08-15

Similar Documents

Publication Publication Date Title
MX2012002089A (es) Composiciones alcoholicas que tienen un riesgo reducido de acetaldehidemia.
BR112014014341A2 (pt) Intermediário metilado, seu método de preparação e seus usos, e composição farmacêutica
DOP2007000078A (es) Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1
BR112014012727A8 (pt) cloridreto derivado de purinona
BR112013000537A2 (pt) composição aquosa contendo bromexina
BRPI0924653B8 (pt) composto de ferro-oligossacarídeo, composição e uso de deste composto
UY32937A (es) Compuestos y composiciones como moduladores de la actividad de gpr119
CO6480918A2 (es) Antagonistas policíclicos de receptores de ácido lisofosfatídico.
DOP2012000124A (es) Derivados de la cromenona con actividad anti-tumoral
WO2010094009A3 (en) Methods and compositions for the treatment of ras associated disorders
BR112014007622A2 (pt) inibidores de flt3 cinase macrocíclicos
CO6410279A2 (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
PE20140500A1 (es) Bebida refrescante
BR112014000792A2 (pt) compostos de piperidinila para uso como inibidores da tanquirase
JP2013502227A5 (enExample)
BR112012013487A2 (pt) Composições de amantadina e métodos de uso
CO6640327A2 (es) Compuestos de pirazol como inhibidores del receptor sigma
UY31922A (es) Compuestos
WO2010006239A3 (en) Regulation of apoptosis by neural specific splice variants of ig20
CO6341543A2 (es) Composiciones mucoadherentes y sus usos
ECSP11011048A (es) Inhibidores de cinasa akt y p70 s6
GT201400003A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
BR112015026884A2 (pt) composição de bebida alcoólica para a provisão de proteção hepática sinérgica; processo para a preparação de uma composição de bebida alcoólica; utilização da composição de bebida alcoólica e bebida alcoólica
MX2012007227A (es) Composicion farmaceutica que comprende analogo de vitamina d y mezcla de cosolvente-tensioactivo.
CL2010001566A1 (es) Compuesto derivado de piperidinilo, modulador de la actividad de los receptores de la quimiocina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias, alergicas, autoinmune.

Legal Events

Date Code Title Description
FC Application refused